CLEVELAND, Ohio — A recent clinical trial led by the University of Cincinnati looked at whether people living with HIV were ...

Oral GLP-1 vs injection: which works better? Experts explain why injections still lead in weight loss—and how new oral ...

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

Add Yahoo as a preferred source to see more of our stories on Google. AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the ...

A recent study has found that lenacapavir, an injectable medication administered twice a year, is more effective at preventing HIV among gay, bisexual, and transgender people than a daily regimen of ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight loss on the skin and the importance of ...

HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Participants Remaining HIV Negative Gilead Launches ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...

A medication offered to heroin abusers at the Albany County jail was shown to help prevent addicts from returning to illegal drug use, according to a study published Wednesday in the New England ...

SEATTLE — Computer scientists and doctors at the University of Washington have found a way for artificial intelligence to deter a concerning incidence in healthcare: medication errors. Errors in ...

The Ministry of Health has issued a warning about the YEZTUGO injectable drug, which has not been licensed for circulation, ...